[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fVJBHWkGwzXHOCnAiezzSkKS6d2-ocwza_GDzdY_cJj4":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":83,"rows":90},"University of Malaya",[4],263,false,38,9,33341,18,197,[14,17,19,22,24,26,29,31],{"name":15,"count":16},"Critical Illness",6,{"name":18,"count":16},"Periodontitis",{"name":20,"count":21},"Orthodontic Appliance Complication",5,{"name":23,"count":21},"Depression",{"name":25,"count":21},"Postoperative Pain",{"name":27,"count":28},"Quality of Life",4,{"name":30,"count":28},"Stroke",{"name":32,"count":28},"Dental Anxiety",[34,39,44,48,53,58,63,68,73,78],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06947161","Pilot Study of Throat Packs Soaked in Gengigel Spray in Patients Undergoing Elective Surgery","2025-08-12","Gengigel",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT05286619","A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent\u002FMetastatic Head and Neck Squamous Cell Carcinoma (PIPER)","2025-12","Pembrolizumab",{"nctId":45,"briefTitle":46,"date":47,"intervention":43},"NCT03989089","Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation","2025-12-01",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT06540885","A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine Surgery","2026-07-31","Palonosetron",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT07068048","Intra-operative Steroid Irrigation for Reducing Recurrent Laryngeal Nerve Palsy Post-thyroidectomy","2026-08-30","Dexametasone",{"nctId":59,"briefTitle":60,"date":61,"intervention":62},"NCT07154446","Study Comparing Dynastat and Parestat Pain Relief Medications for Patients After Breast Surgery","2026-08-31","Parestat",{"nctId":64,"briefTitle":65,"date":66,"intervention":67},"NCT07614607","Evaluating the Efficacy and Utility of the Automated Pupillometer in Pain Assessment and Opioid Administration Guidance During the Perioperative Period: A Randomized Controlled Trial","2026-12","Opioid Analgesic",{"nctId":69,"briefTitle":70,"date":71,"intervention":72},"NCT07452705","Small Study Comparing Two Pain Medicines in Teenagers for Pain Control After Scoliosis Corrective Surgery.","2027-07-01","Ketamine-Morphine PCA",{"nctId":74,"briefTitle":75,"date":76,"intervention":77},"NCT07398066","DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)","2027-07-22","Dexmedetomidine",{"nctId":79,"briefTitle":80,"date":81,"intervention":82},"NCT07176065","Dexmedetomidine as an Adjunct to Periarticular Ropivacaine in Total Knee Replacement: A Pilot Randomised Controlled Trial","2027-12","Ropivacaine + saline solution",[84,85,86,87,88,89],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[91,132,155,173,195,213,231,264,282,300,318,338,423,456,474,492,515,533,555,581,608,626,650,676,701,727,745,771,789,814,840,858,884,902,929,947,973,998,1025,1043,1068,1095,1113,1139,1157,1185,1203,1221,1244,1268,1293,1311,1339,1357,1384,1402,1428,1455,1473,1500,1526,1544,1562,1588,1613,1638,1663,1691,1709,1734,1762,1780,1798,1816,1840,1858,1905,1931,1953,1978,2003,2027,2052,2078,2096,2120,2138,2165,2183,2208,2226,2250,2268,2286,2310,2336,2354],{"intervention":52,"totalTrials":92,"cells":93},2,{"EARLY_PHASE1":94,"PHASE1":97,"PHASE2":99,"PHASE3":101,"PHASE4":103,"NA":130},{"trials":95,"activeCount":96},[],0,{"trials":98,"activeCount":96},[],{"trials":100,"activeCount":96},[],{"trials":102,"activeCount":96},[],{"trials":104,"activeCount":129,"soonestReadout":51},[105,119],{"nctId":106,"briefTitle":107,"status":108,"phases":109,"primaryCompletion":110,"completion":111,"start":112,"enrollment":113,"conditions":114,"interventions":117},"NCT05956899","Palonosetron vs Ondansetron In PONV Prophylaxis Among Idiopathic Scoliosis Patients","COMPLETED",[88],"2024-03-20","2024-05-02","2023-06-01",92,[115,116],"Idiopathic Scoliosis","Postoperative Nausea and Vomiting",[52,118],"Ondansetron",{"nctId":49,"briefTitle":50,"status":120,"phases":121,"primaryCompletion":51,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":127},"RECRUITING",[88],"2026-09-30","2025-01-06",74,[116,126],"Scoliosis",[52,128],"Granisetron",1,{"trials":131,"activeCount":96},[],{"intervention":62,"totalTrials":129,"cells":133},{"EARLY_PHASE1":134,"PHASE1":136,"PHASE2":138,"PHASE3":140,"PHASE4":142,"NA":153},{"trials":135,"activeCount":96},[],{"trials":137,"activeCount":96},[],{"trials":139,"activeCount":96},[],{"trials":141,"activeCount":96},[],{"trials":143,"activeCount":129,"soonestReadout":61},[144],{"nctId":59,"briefTitle":60,"status":145,"phases":146,"primaryCompletion":61,"completion":66,"start":147,"enrollment":148,"conditions":149,"interventions":151},"NOT_YET_RECRUITING",[88],"2025-10-01",60,[150],"Breast Exicision Biopsy",[62,152],"Dynastat",{"trials":154,"activeCount":96},[],{"intervention":152,"totalTrials":129,"cells":156},{"EARLY_PHASE1":157,"PHASE1":159,"PHASE2":161,"PHASE3":163,"PHASE4":165,"NA":171},{"trials":158,"activeCount":96},[],{"trials":160,"activeCount":96},[],{"trials":162,"activeCount":96},[],{"trials":164,"activeCount":96},[],{"trials":166,"activeCount":129,"soonestReadout":61},[167],{"nctId":59,"briefTitle":60,"status":145,"phases":168,"primaryCompletion":61,"completion":66,"start":147,"enrollment":148,"conditions":169,"interventions":170},[88],[150],[62,152],{"trials":172,"activeCount":96},[],{"intervention":82,"totalTrials":129,"cells":174},{"EARLY_PHASE1":175,"PHASE1":177,"PHASE2":179,"PHASE3":181,"PHASE4":183,"NA":193},{"trials":176,"activeCount":96},[],{"trials":178,"activeCount":96},[],{"trials":180,"activeCount":96},[],{"trials":182,"activeCount":96},[],{"trials":184,"activeCount":129,"soonestReadout":81},[185],{"nctId":79,"briefTitle":80,"status":145,"phases":186,"primaryCompletion":81,"completion":187,"start":188,"enrollment":148,"conditions":189,"interventions":191},[88],"2028-12","2025-10",[190],"Postoperative Pain Management in Total Knee Arthroplasty",[82,192],"Ropivacaine + Dexmedetomidine",{"trials":194,"activeCount":96},[],{"intervention":192,"totalTrials":129,"cells":196},{"EARLY_PHASE1":197,"PHASE1":199,"PHASE2":201,"PHASE3":203,"PHASE4":205,"NA":211},{"trials":198,"activeCount":96},[],{"trials":200,"activeCount":96},[],{"trials":202,"activeCount":96},[],{"trials":204,"activeCount":96},[],{"trials":206,"activeCount":129,"soonestReadout":81},[207],{"nctId":79,"briefTitle":80,"status":145,"phases":208,"primaryCompletion":81,"completion":187,"start":188,"enrollment":148,"conditions":209,"interventions":210},[88],[190],[82,192],{"trials":212,"activeCount":96},[],{"intervention":128,"totalTrials":129,"cells":214},{"EARLY_PHASE1":215,"PHASE1":217,"PHASE2":219,"PHASE3":221,"PHASE4":223,"NA":229},{"trials":216,"activeCount":96},[],{"trials":218,"activeCount":96},[],{"trials":220,"activeCount":96},[],{"trials":222,"activeCount":96},[],{"trials":224,"activeCount":129,"soonestReadout":51},[225],{"nctId":49,"briefTitle":50,"status":120,"phases":226,"primaryCompletion":51,"completion":122,"start":123,"enrollment":124,"conditions":227,"interventions":228},[88],[116,126],[52,128],{"trials":230,"activeCount":96},[],{"intervention":43,"totalTrials":92,"cells":232},{"EARLY_PHASE1":233,"PHASE1":235,"PHASE2":237,"PHASE3":258,"PHASE4":260,"NA":262},{"trials":234,"activeCount":96},[],{"trials":236,"activeCount":96},[],{"trials":238,"activeCount":92,"soonestReadout":42},[239,248],{"nctId":45,"briefTitle":46,"status":240,"phases":241,"primaryCompletion":47,"completion":242,"start":243,"enrollment":244,"conditions":245,"interventions":247},"ACTIVE_NOT_RECRUITING",[86],"2026-12-01","2020-07-03",44,[246],"HER2-Negative Breast Cancer",[43],{"nctId":40,"briefTitle":41,"status":120,"phases":249,"primaryCompletion":42,"completion":187,"start":250,"enrollment":251,"conditions":252,"interventions":254},[86],"2022-09-22",63,[253],"Recurrent\u002FMetastatic Head and Neck Squamous Cell Carcinoma",[43,255,256,257],"Cisplatin","Carboplatin","Gemcitabine",{"trials":259,"activeCount":96},[],{"trials":261,"activeCount":96},[],{"trials":263,"activeCount":96},[],{"intervention":255,"totalTrials":129,"cells":265},{"EARLY_PHASE1":266,"PHASE1":268,"PHASE2":270,"PHASE3":276,"PHASE4":278,"NA":280},{"trials":267,"activeCount":96},[],{"trials":269,"activeCount":96},[],{"trials":271,"activeCount":129,"soonestReadout":42},[272],{"nctId":40,"briefTitle":41,"status":120,"phases":273,"primaryCompletion":42,"completion":187,"start":250,"enrollment":251,"conditions":274,"interventions":275},[86],[253],[43,255,256,257],{"trials":277,"activeCount":96},[],{"trials":279,"activeCount":96},[],{"trials":281,"activeCount":96},[],{"intervention":256,"totalTrials":129,"cells":283},{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":294,"PHASE4":296,"NA":298},{"trials":285,"activeCount":96},[],{"trials":287,"activeCount":96},[],{"trials":289,"activeCount":129,"soonestReadout":42},[290],{"nctId":40,"briefTitle":41,"status":120,"phases":291,"primaryCompletion":42,"completion":187,"start":250,"enrollment":251,"conditions":292,"interventions":293},[86],[253],[43,255,256,257],{"trials":295,"activeCount":96},[],{"trials":297,"activeCount":96},[],{"trials":299,"activeCount":96},[],{"intervention":257,"totalTrials":129,"cells":301},{"EARLY_PHASE1":302,"PHASE1":304,"PHASE2":306,"PHASE3":312,"PHASE4":314,"NA":316},{"trials":303,"activeCount":96},[],{"trials":305,"activeCount":96},[],{"trials":307,"activeCount":129,"soonestReadout":42},[308],{"nctId":40,"briefTitle":41,"status":120,"phases":309,"primaryCompletion":42,"completion":187,"start":250,"enrollment":251,"conditions":310,"interventions":311},[86],[253],[43,255,256,257],{"trials":313,"activeCount":96},[],{"trials":315,"activeCount":96},[],{"trials":317,"activeCount":96},[],{"intervention":38,"totalTrials":129,"cells":319},{"EARLY_PHASE1":320,"PHASE1":328,"PHASE2":330,"PHASE3":332,"PHASE4":334,"NA":336},{"trials":321,"activeCount":129,"soonestReadout":37},[322],{"nctId":35,"briefTitle":36,"status":120,"phases":323,"primaryCompletion":37,"completion":37,"start":324,"enrollment":148,"conditions":325,"interventions":327},[84],"2025-02-12",[326],"Throat, Sore",[38],{"trials":329,"activeCount":96},[],{"trials":331,"activeCount":96},[],{"trials":333,"activeCount":96},[],{"trials":335,"activeCount":96},[],{"trials":337,"activeCount":96},[],{"intervention":339,"totalTrials":16,"cells":340},"Normal saline",{"EARLY_PHASE1":341,"PHASE1":343,"PHASE2":345,"PHASE3":347,"PHASE4":349,"NA":376},{"trials":342,"activeCount":96},[],{"trials":344,"activeCount":96},[],{"trials":346,"activeCount":96},[],{"trials":348,"activeCount":96},[],{"trials":350,"activeCount":96},[351,363],{"nctId":352,"briefTitle":353,"status":354,"phases":355,"primaryCompletion":356,"completion":356,"start":357,"enrollment":358,"conditions":359,"interventions":361},"NCT04491357","Prophylactic Infusion of Calcium Gluconate Reducing the Rate of Hypocalcaemia After Total Thyroidectomy","UNKNOWN",[88],"2022-06-01","2020-06-01",50,[360],"Hypocalcemia",[362,339],"Calcium Gluconate",{"nctId":364,"briefTitle":365,"status":108,"phases":366,"primaryCompletion":367,"completion":368,"start":369,"enrollment":370,"conditions":371,"interventions":374},"NCT04931433","Intravenous Lignocaine as an Analgesic Adjunct in Adolescent Idiopathic Scoliosis Surgery",[88],"2022-03-31","2022-09-30","2020-12-24",115,[372,373],"Adolescent Idiopathic Scoliosis","Analgesia",[375,339],"Lignocaine",{"trials":377,"activeCount":129,"soonestReadout":76},[378,388,400,411],{"nctId":74,"briefTitle":75,"status":145,"phases":379,"primaryCompletion":76,"completion":380,"start":381,"enrollment":148,"conditions":382,"interventions":386},[89],"2027-08-22","2026-07-22",[383,384,385],"Neurosurgery","Brain Cancer","Meningioma",[77,387],"Normal Saline",{"nctId":389,"briefTitle":390,"status":354,"phases":391,"primaryCompletion":392,"completion":393,"start":394,"enrollment":395,"conditions":396,"interventions":399},"NCT04052867","Intravenous Lignocaine Infusion in Laparoscopic Donor Nephrectomy",[89],"2021-07-15","2021-07-31","2019-09-17",40,[25,397,398],"Renal Transplantation","Morphine Adverse Reaction",[375,339],{"nctId":401,"briefTitle":402,"status":108,"phases":403,"primaryCompletion":404,"completion":404,"start":405,"enrollment":406,"conditions":407,"interventions":410},"NCT05897385","Analgesic Effect of IntraPeritoneal LIGNOcaine in Gynaecological Open Surgery",[89],"2026-01-08","2023-08-22",112,[25,408,409],"Gynecologic Disease","Local Anesthetic Systemic Toxicity",[375,387],{"nctId":412,"briefTitle":413,"status":108,"phases":414,"primaryCompletion":415,"completion":415,"start":416,"enrollment":417,"conditions":418,"interventions":420},"NCT01815944","Onset Time of Brachial Plexus Block Using Local Anaesthetic Diluted With 0.9% Saline vs 5% Dextrose",[89],"2012-10","2011-12",55,[419],"Comparison of Onset Time",[421,339,422],"0.75% Ropivacaine","Dextrose 5%",{"intervention":424,"totalTrials":92,"cells":425},"Morphine",{"EARLY_PHASE1":426,"PHASE1":428,"PHASE2":440,"PHASE3":442,"PHASE4":444,"NA":446},{"trials":427,"activeCount":96},[],{"trials":429,"activeCount":96},[430],{"nctId":431,"briefTitle":432,"status":354,"phases":433,"primaryCompletion":434,"completion":434,"start":435,"enrollment":395,"conditions":436,"interventions":438},"NCT02014714","Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea",[85],"2014-06","2013-12",[437],"Obstructive Sleep Apnea of Adult",[424,439],"Fentanyl",{"trials":441,"activeCount":96},[],{"trials":443,"activeCount":96},[],{"trials":445,"activeCount":96},[],{"trials":447,"activeCount":129,"soonestReadout":71},[448],{"nctId":69,"briefTitle":70,"status":145,"phases":449,"primaryCompletion":71,"completion":450,"start":451,"enrollment":452,"conditions":453,"interventions":455},[89],"2028-01-30","2026-02-02",114,[454],"Adolescent Idiopathic Scoliosis (AIS)",[72,424],{"intervention":77,"totalTrials":129,"cells":457},{"EARLY_PHASE1":458,"PHASE1":460,"PHASE2":462,"PHASE3":464,"PHASE4":466,"NA":468},{"trials":459,"activeCount":96},[],{"trials":461,"activeCount":96},[],{"trials":463,"activeCount":96},[],{"trials":465,"activeCount":96},[],{"trials":467,"activeCount":96},[],{"trials":469,"activeCount":129,"soonestReadout":76},[470],{"nctId":74,"briefTitle":75,"status":145,"phases":471,"primaryCompletion":76,"completion":380,"start":381,"enrollment":148,"conditions":472,"interventions":473},[89],[383,384,385],[77,387],{"intervention":72,"totalTrials":129,"cells":475},{"EARLY_PHASE1":476,"PHASE1":478,"PHASE2":480,"PHASE3":482,"PHASE4":484,"NA":486},{"trials":477,"activeCount":96},[],{"trials":479,"activeCount":96},[],{"trials":481,"activeCount":96},[],{"trials":483,"activeCount":96},[],{"trials":485,"activeCount":96},[],{"trials":487,"activeCount":129,"soonestReadout":71},[488],{"nctId":69,"briefTitle":70,"status":145,"phases":489,"primaryCompletion":71,"completion":450,"start":451,"enrollment":452,"conditions":490,"interventions":491},[89],[454],[72,424],{"intervention":57,"totalTrials":129,"cells":493},{"EARLY_PHASE1":494,"PHASE1":496,"PHASE2":498,"PHASE3":500,"PHASE4":502,"NA":504},{"trials":495,"activeCount":96},[],{"trials":497,"activeCount":96},[],{"trials":499,"activeCount":96},[],{"trials":501,"activeCount":96},[],{"trials":503,"activeCount":96},[],{"trials":505,"activeCount":129,"soonestReadout":56},[506],{"nctId":54,"briefTitle":55,"status":507,"phases":508,"primaryCompletion":56,"completion":56,"start":509,"enrollment":510,"conditions":511,"interventions":513},"ENROLLING_BY_INVITATION",[89],"2024-08-30",100,[512],"Nerve Condition",[57,514],"Water for",{"intervention":514,"totalTrials":129,"cells":516},{"EARLY_PHASE1":517,"PHASE1":519,"PHASE2":521,"PHASE3":523,"PHASE4":525,"NA":527},{"trials":518,"activeCount":96},[],{"trials":520,"activeCount":96},[],{"trials":522,"activeCount":96},[],{"trials":524,"activeCount":96},[],{"trials":526,"activeCount":96},[],{"trials":528,"activeCount":129,"soonestReadout":56},[529],{"nctId":54,"briefTitle":55,"status":507,"phases":530,"primaryCompletion":56,"completion":56,"start":509,"enrollment":510,"conditions":531,"interventions":532},[89],[512],[57,514],{"intervention":67,"totalTrials":129,"cells":534},{"EARLY_PHASE1":535,"PHASE1":537,"PHASE2":539,"PHASE3":541,"PHASE4":543,"NA":545},{"trials":536,"activeCount":96},[],{"trials":538,"activeCount":96},[],{"trials":540,"activeCount":96},[],{"trials":542,"activeCount":96},[],{"trials":544,"activeCount":96},[],{"trials":546,"activeCount":129,"soonestReadout":66},[547],{"nctId":64,"briefTitle":65,"status":240,"phases":548,"primaryCompletion":66,"completion":549,"start":550,"enrollment":551,"conditions":552,"interventions":554},[89],"2027-02","2026-05-01",68,[25,553],"Postoperative Pain Management",[67],{"intervention":556,"totalTrials":129,"cells":557},"NPH basal insulin titration",{"EARLY_PHASE1":558,"PHASE1":560,"PHASE2":562,"PHASE3":564,"PHASE4":566,"NA":579},{"trials":559,"activeCount":96},[],{"trials":561,"activeCount":96},[],{"trials":563,"activeCount":96},[],{"trials":565,"activeCount":96},[],{"trials":567,"activeCount":96},[568],{"nctId":569,"briefTitle":570,"status":354,"phases":571,"primaryCompletion":572,"completion":573,"start":574,"enrollment":575,"conditions":576,"interventions":578},"NCT05331469","Difference of Basal Insulin Titration Method in Reducing HbA1c Among Type 2 Diabetes Mellitus (T2DM) Patients.",[88],"2022-08-31","2023-04-30","2021-07-19",70,[577],"to Identify Which Titration Regimen of Basal Insulin (Being Daily Titration vs 3 Daily Titration) is Better in Reducing hba1c and Have Lesser Hypoglycemia",[556],{"trials":580,"activeCount":96},[],{"intervention":582,"totalTrials":129,"cells":583},"Rebamipide",{"EARLY_PHASE1":584,"PHASE1":586,"PHASE2":588,"PHASE3":590,"PHASE4":592,"NA":606},{"trials":585,"activeCount":96},[],{"trials":587,"activeCount":96},[],{"trials":589,"activeCount":96},[],{"trials":591,"activeCount":96},[],{"trials":593,"activeCount":96},[594],{"nctId":595,"briefTitle":596,"status":354,"phases":597,"primaryCompletion":598,"completion":599,"start":600,"enrollment":601,"conditions":602,"interventions":604},"NCT02134405","Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia",[88],"2016-06","2016-12","2014-08",200,[603],"Dyspepsia",[582,605],"Esomeprazole",{"trials":607,"activeCount":96},[],{"intervention":605,"totalTrials":129,"cells":609},{"EARLY_PHASE1":610,"PHASE1":612,"PHASE2":614,"PHASE3":616,"PHASE4":618,"NA":624},{"trials":611,"activeCount":96},[],{"trials":613,"activeCount":96},[],{"trials":615,"activeCount":96},[],{"trials":617,"activeCount":96},[],{"trials":619,"activeCount":96},[620],{"nctId":595,"briefTitle":596,"status":354,"phases":621,"primaryCompletion":598,"completion":599,"start":600,"enrollment":601,"conditions":622,"interventions":623},[88],[603],[582,605],{"trials":625,"activeCount":96},[],{"intervention":627,"totalTrials":129,"cells":628},"Vaginal Hyal gel 2.5g",{"EARLY_PHASE1":629,"PHASE1":631,"PHASE2":633,"PHASE3":635,"PHASE4":637,"NA":648},{"trials":630,"activeCount":96},[],{"trials":632,"activeCount":96},[],{"trials":634,"activeCount":96},[],{"trials":636,"activeCount":96},[],{"trials":638,"activeCount":96},[639],{"nctId":640,"briefTitle":641,"status":108,"phases":642,"primaryCompletion":643,"completion":643,"start":644,"enrollment":575,"conditions":645,"interventions":647},"NCT06964646","Assess Efficacy, Safety, and Tolerability of 8 Weeks of Vaginal Hyaluronic (V-HYAL) Gel in Peri- and Post-Menopausal Female",[88],"2024-06-27","2024-01-08",[646],"Vaginal Dryness",[627],{"trials":649,"activeCount":96},[],{"intervention":651,"totalTrials":129,"cells":652},"Empagliflozin",{"EARLY_PHASE1":653,"PHASE1":655,"PHASE2":657,"PHASE3":659,"PHASE4":661,"NA":674},{"trials":654,"activeCount":96},[],{"trials":656,"activeCount":96},[],{"trials":658,"activeCount":96},[],{"trials":660,"activeCount":96},[],{"trials":662,"activeCount":96},[663],{"nctId":664,"briefTitle":665,"status":354,"phases":666,"primaryCompletion":667,"completion":667,"start":668,"enrollment":669,"conditions":670,"interventions":673},"NCT02964715","The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes",[88],"2018-11","2016-11",25,[671,672],"Type2 Diabetes","NAFLD",[651],{"trials":675,"activeCount":96},[],{"intervention":677,"totalTrials":129,"cells":678},"Nebulized 5% Hypertonic saline",{"EARLY_PHASE1":679,"PHASE1":681,"PHASE2":683,"PHASE3":685,"PHASE4":687,"NA":699},{"trials":680,"activeCount":96},[],{"trials":682,"activeCount":96},[],{"trials":684,"activeCount":96},[],{"trials":686,"activeCount":96},[],{"trials":688,"activeCount":96},[689],{"nctId":690,"briefTitle":691,"status":108,"phases":692,"primaryCompletion":693,"completion":693,"start":694,"enrollment":695,"conditions":696,"interventions":698},"NCT04765033","Trial on The Efficacy of Hypertonic Saline on Non-CF CSLD.",[88],"2023-08-28","2021-02-04",46,[697],"Bronchiectasis",[677],{"trials":700,"activeCount":96},[],{"intervention":702,"totalTrials":129,"cells":703},"Ziprasidone",{"EARLY_PHASE1":704,"PHASE1":706,"PHASE2":708,"PHASE3":710,"PHASE4":712,"NA":725},{"trials":705,"activeCount":96},[],{"trials":707,"activeCount":96},[],{"trials":709,"activeCount":96},[],{"trials":711,"activeCount":96},[],{"trials":713,"activeCount":96},[714],{"nctId":715,"briefTitle":716,"status":108,"phases":717,"primaryCompletion":718,"completion":718,"start":719,"enrollment":720,"conditions":721,"interventions":723},"NCT01714011","Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome",[88],"2011-09","2009-05",175,[722],"Schizophrenia",[702,724],"Aripiprazole",{"trials":726,"activeCount":96},[],{"intervention":724,"totalTrials":129,"cells":728},{"EARLY_PHASE1":729,"PHASE1":731,"PHASE2":733,"PHASE3":735,"PHASE4":737,"NA":743},{"trials":730,"activeCount":96},[],{"trials":732,"activeCount":96},[],{"trials":734,"activeCount":96},[],{"trials":736,"activeCount":96},[],{"trials":738,"activeCount":96},[739],{"nctId":715,"briefTitle":716,"status":108,"phases":740,"primaryCompletion":718,"completion":718,"start":719,"enrollment":720,"conditions":741,"interventions":742},[88],[722],[702,724],{"trials":744,"activeCount":96},[],{"intervention":746,"totalTrials":129,"cells":747},"Umbilical cord-mesenchymal stem cells",{"EARLY_PHASE1":748,"PHASE1":750,"PHASE2":752,"PHASE3":754,"PHASE4":756,"NA":769},{"trials":749,"activeCount":96},[],{"trials":751,"activeCount":96},[],{"trials":753,"activeCount":96},[],{"trials":755,"activeCount":96},[],{"trials":757,"activeCount":96},[758],{"nctId":759,"briefTitle":760,"status":354,"phases":761,"primaryCompletion":762,"completion":763,"start":764,"enrollment":765,"conditions":766,"interventions":768},"NCT06388447","Reconstruction of Deficient Interdental Papilla Using Stem Cells vs Physiological Saline",[88],"2024-12-31","2025-03-30","2023-12-01",20,[767],"Gingival Recession, Localized",[746],{"trials":770,"activeCount":96},[],{"intervention":362,"totalTrials":129,"cells":772},{"EARLY_PHASE1":773,"PHASE1":775,"PHASE2":777,"PHASE3":779,"PHASE4":781,"NA":787},{"trials":774,"activeCount":96},[],{"trials":776,"activeCount":96},[],{"trials":778,"activeCount":96},[],{"trials":780,"activeCount":96},[],{"trials":782,"activeCount":96},[783],{"nctId":352,"briefTitle":353,"status":354,"phases":784,"primaryCompletion":356,"completion":356,"start":357,"enrollment":358,"conditions":785,"interventions":786},[88],[360],[362,339],{"trials":788,"activeCount":96},[],{"intervention":790,"totalTrials":129,"cells":791},"Oxycodone",{"EARLY_PHASE1":792,"PHASE1":794,"PHASE2":796,"PHASE3":798,"PHASE4":800,"NA":812},{"trials":793,"activeCount":96},[],{"trials":795,"activeCount":96},[],{"trials":797,"activeCount":96},[],{"trials":799,"activeCount":96},[],{"trials":801,"activeCount":96},[802],{"nctId":803,"briefTitle":804,"status":108,"phases":805,"primaryCompletion":806,"completion":806,"start":807,"enrollment":808,"conditions":809,"interventions":811},"NCT02728648","Population Pharmacokinetic-Pharmacodynamic Study of Intravenous Oxycodone in Malaysian Population",[88],"2017-11","2016-04",33,[810],"Pain",[790],{"trials":813,"activeCount":96},[],{"intervention":815,"totalTrials":129,"cells":816},"Rotator interval hydro-dissection with dextrose 5%",{"EARLY_PHASE1":817,"PHASE1":819,"PHASE2":821,"PHASE3":823,"PHASE4":825,"NA":838},{"trials":818,"activeCount":96},[],{"trials":820,"activeCount":96},[],{"trials":822,"activeCount":96},[],{"trials":824,"activeCount":96},[],{"trials":826,"activeCount":96},[827],{"nctId":828,"briefTitle":829,"status":354,"phases":830,"primaryCompletion":831,"completion":832,"start":833,"enrollment":148,"conditions":834,"interventions":836},"NCT05977985","The Effects of Rotator Interval Hydro-dissection in Primary Adhesive Capsulitis.",[88],"2024-07-01","2025-07-01","2023-08-01",[835],"Adhesive Capsulitis of Shoulder",[815,837],"Rotator interval hydro-dissection with corticosteroid solution",{"trials":839,"activeCount":96},[],{"intervention":837,"totalTrials":129,"cells":841},{"EARLY_PHASE1":842,"PHASE1":844,"PHASE2":846,"PHASE3":848,"PHASE4":850,"NA":856},{"trials":843,"activeCount":96},[],{"trials":845,"activeCount":96},[],{"trials":847,"activeCount":96},[],{"trials":849,"activeCount":96},[],{"trials":851,"activeCount":96},[852],{"nctId":828,"briefTitle":829,"status":354,"phases":853,"primaryCompletion":831,"completion":832,"start":833,"enrollment":148,"conditions":854,"interventions":855},[88],[835],[815,837],{"trials":857,"activeCount":96},[],{"intervention":859,"totalTrials":129,"cells":860},"Treatment based on subtypes: Esomeprazole or Itopride",{"EARLY_PHASE1":861,"PHASE1":863,"PHASE2":865,"PHASE3":867,"PHASE4":869,"NA":882},{"trials":862,"activeCount":96},[],{"trials":864,"activeCount":96},[],{"trials":866,"activeCount":96},[],{"trials":868,"activeCount":96},[],{"trials":870,"activeCount":96},[871],{"nctId":872,"briefTitle":873,"status":354,"phases":874,"primaryCompletion":875,"completion":875,"start":876,"enrollment":877,"conditions":878,"interventions":880},"NCT04918017","Treatment Outcomes For Functional Dyspepsia Based On Current International Guidelines In Multi-Ethnic Asian Patients",[88],"2023-12-31","2021-11-18",180,[879],"Functional Dyspepsia",[859,881],"Treatment with proton pump inhibitor regardless of subtype: Esomeprazole",{"trials":883,"activeCount":96},[],{"intervention":881,"totalTrials":129,"cells":885},{"EARLY_PHASE1":886,"PHASE1":888,"PHASE2":890,"PHASE3":892,"PHASE4":894,"NA":900},{"trials":887,"activeCount":96},[],{"trials":889,"activeCount":96},[],{"trials":891,"activeCount":96},[],{"trials":893,"activeCount":96},[],{"trials":895,"activeCount":96},[896],{"nctId":872,"briefTitle":873,"status":354,"phases":897,"primaryCompletion":875,"completion":875,"start":876,"enrollment":877,"conditions":898,"interventions":899},[88],[879],[859,881],{"trials":901,"activeCount":96},[],{"intervention":903,"totalTrials":129,"cells":904},"Sevoflurane inhalant product",{"EARLY_PHASE1":905,"PHASE1":907,"PHASE2":909,"PHASE3":911,"PHASE4":913,"NA":927},{"trials":906,"activeCount":96},[],{"trials":908,"activeCount":96},[],{"trials":910,"activeCount":96},[],{"trials":912,"activeCount":96},[],{"trials":914,"activeCount":96},[915],{"nctId":916,"briefTitle":917,"status":354,"phases":918,"primaryCompletion":367,"completion":919,"start":920,"enrollment":921,"conditions":922,"interventions":926},"NCT04839536","Comparing Sevoflurane With Propofol Sedation in ESRF Patients",[88],"2022-04-30","2021-04-01",36,[923,924,925],"Sevoflurane","Kidney Diseases","Procedural Hypotension",[903],{"trials":928,"activeCount":96},[],{"intervention":118,"totalTrials":129,"cells":930},{"EARLY_PHASE1":931,"PHASE1":933,"PHASE2":935,"PHASE3":937,"PHASE4":939,"NA":945},{"trials":932,"activeCount":96},[],{"trials":934,"activeCount":96},[],{"trials":936,"activeCount":96},[],{"trials":938,"activeCount":96},[],{"trials":940,"activeCount":96},[941],{"nctId":106,"briefTitle":107,"status":108,"phases":942,"primaryCompletion":110,"completion":111,"start":112,"enrollment":113,"conditions":943,"interventions":944},[88],[115,116],[52,118],{"trials":946,"activeCount":96},[],{"intervention":948,"totalTrials":129,"cells":949},"Ketorolac tromethamine ophthalmic solution 0.45%",{"EARLY_PHASE1":950,"PHASE1":952,"PHASE2":954,"PHASE3":956,"PHASE4":958,"NA":971},{"trials":951,"activeCount":96},[],{"trials":953,"activeCount":96},[],{"trials":955,"activeCount":96},[],{"trials":957,"activeCount":96},[],{"trials":959,"activeCount":96},[960],{"nctId":961,"briefTitle":962,"status":108,"phases":963,"primaryCompletion":964,"completion":965,"start":600,"enrollment":966,"conditions":967,"interventions":970},"NCT02646072","Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients",[88],"2015-05","2015-06",80,[968,969],"Cystoid Macular Edema, Postoperative","Diabetes Mellitus",[948],{"trials":972,"activeCount":96},[],{"intervention":974,"totalTrials":129,"cells":975},"Rifaximin",{"EARLY_PHASE1":976,"PHASE1":978,"PHASE2":980,"PHASE3":982,"PHASE4":984,"NA":996},{"trials":977,"activeCount":96},[],{"trials":979,"activeCount":96},[],{"trials":981,"activeCount":96},[],{"trials":983,"activeCount":96},[],{"trials":985,"activeCount":96},[986],{"nctId":987,"briefTitle":988,"status":354,"phases":989,"primaryCompletion":990,"completion":990,"start":991,"enrollment":510,"conditions":992,"interventions":995},"NCT04841980","Rifaximin Therapy vs Low FODMAP Diet In IBS",[88],"2024-05-31","2021-04-22",[993,994],"Irritable Bowel Syndrome","Small Intestinal Bacterial Overgrowth",[974],{"trials":997,"activeCount":96},[],{"intervention":999,"totalTrials":129,"cells":1000},"Iron Isomaltoside 1000",{"EARLY_PHASE1":1001,"PHASE1":1003,"PHASE2":1005,"PHASE3":1007,"PHASE4":1009,"NA":1023},{"trials":1002,"activeCount":96},[],{"trials":1004,"activeCount":96},[],{"trials":1006,"activeCount":96},[],{"trials":1008,"activeCount":96},[],{"trials":1010,"activeCount":96},[1011],{"nctId":1012,"briefTitle":1013,"status":354,"phases":1014,"primaryCompletion":1015,"completion":1016,"start":1017,"enrollment":148,"conditions":1018,"interventions":1021},"NCT04505514","Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage",[88],"2022-10-31","2022-12-31","2020-08-01",[1019,1020],"Post Partum Hemorrhage","Anemia",[999,1022],"Iberet-Folic-500",{"trials":1024,"activeCount":96},[],{"intervention":1022,"totalTrials":129,"cells":1026},{"EARLY_PHASE1":1027,"PHASE1":1029,"PHASE2":1031,"PHASE3":1033,"PHASE4":1035,"NA":1041},{"trials":1028,"activeCount":96},[],{"trials":1030,"activeCount":96},[],{"trials":1032,"activeCount":96},[],{"trials":1034,"activeCount":96},[],{"trials":1036,"activeCount":96},[1037],{"nctId":1012,"briefTitle":1013,"status":354,"phases":1038,"primaryCompletion":1015,"completion":1016,"start":1017,"enrollment":148,"conditions":1039,"interventions":1040},[88],[1019,1020],[999,1022],{"trials":1042,"activeCount":96},[],{"intervention":1044,"totalTrials":129,"cells":1045},"Amoxicillin-Potassium Clavulanate Combination",{"EARLY_PHASE1":1046,"PHASE1":1048,"PHASE2":1050,"PHASE3":1052,"PHASE4":1054,"NA":1066},{"trials":1047,"activeCount":96},[],{"trials":1049,"activeCount":96},[],{"trials":1051,"activeCount":96},[],{"trials":1053,"activeCount":96},[],{"trials":1055,"activeCount":96},[1056],{"nctId":1057,"briefTitle":1058,"status":108,"phases":1059,"primaryCompletion":806,"completion":1060,"start":1061,"enrollment":1062,"conditions":1063,"interventions":1065},"NCT02258763","Trial on the Ideal Duration of Oral Antibiotics in Children With Pneumonia",[88],"2018-10","2014-11",19,[1064],"Pneumonia",[1044],{"trials":1067,"activeCount":96},[],{"intervention":1069,"totalTrials":129,"cells":1070},"Intravenous Ascorbate",{"EARLY_PHASE1":1071,"PHASE1":1073,"PHASE2":1075,"PHASE3":1077,"PHASE4":1091,"NA":1093},{"trials":1072,"activeCount":96},[],{"trials":1074,"activeCount":96},[],{"trials":1076,"activeCount":96},[],{"trials":1078,"activeCount":96},[1079],{"nctId":1080,"briefTitle":1081,"status":354,"phases":1082,"primaryCompletion":1083,"completion":1083,"start":1084,"enrollment":1085,"conditions":1086,"interventions":1089},"NCT05327348","Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery",[87],"2023-07-31","2022-09-25",34,[1087,1088],"Oxidative Stress","Ischemia-reperfusion Injury",[1069,1090],"Normal Saline 10 mL",{"trials":1092,"activeCount":96},[],{"trials":1094,"activeCount":96},[],{"intervention":1090,"totalTrials":129,"cells":1096},{"EARLY_PHASE1":1097,"PHASE1":1099,"PHASE2":1101,"PHASE3":1103,"PHASE4":1109,"NA":1111},{"trials":1098,"activeCount":96},[],{"trials":1100,"activeCount":96},[],{"trials":1102,"activeCount":96},[],{"trials":1104,"activeCount":96},[1105],{"nctId":1080,"briefTitle":1081,"status":354,"phases":1106,"primaryCompletion":1083,"completion":1083,"start":1084,"enrollment":1085,"conditions":1107,"interventions":1108},[87],[1087,1088],[1069,1090],{"trials":1110,"activeCount":96},[],{"trials":1112,"activeCount":96},[],{"intervention":1114,"totalTrials":129,"cells":1115},"Tocilizumab",{"EARLY_PHASE1":1116,"PHASE1":1118,"PHASE2":1120,"PHASE3":1122,"PHASE4":1135,"NA":1137},{"trials":1117,"activeCount":96},[],{"trials":1119,"activeCount":96},[],{"trials":1121,"activeCount":96},[],{"trials":1123,"activeCount":96},[1124],{"nctId":1125,"briefTitle":1126,"status":354,"phases":1127,"primaryCompletion":1128,"completion":1128,"start":1129,"enrollment":1130,"conditions":1131,"interventions":1133},"NCT04345445","Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression",[87],"2020-10-31","2020-04-15",310,[1132],"COVID-19",[1114,1134],"Methylprednisolone",{"trials":1136,"activeCount":96},[],{"trials":1138,"activeCount":96},[],{"intervention":1134,"totalTrials":129,"cells":1140},{"EARLY_PHASE1":1141,"PHASE1":1143,"PHASE2":1145,"PHASE3":1147,"PHASE4":1153,"NA":1155},{"trials":1142,"activeCount":96},[],{"trials":1144,"activeCount":96},[],{"trials":1146,"activeCount":96},[],{"trials":1148,"activeCount":96},[1149],{"nctId":1125,"briefTitle":1126,"status":354,"phases":1150,"primaryCompletion":1128,"completion":1128,"start":1129,"enrollment":1130,"conditions":1151,"interventions":1152},[87],[1132],[1114,1134],{"trials":1154,"activeCount":96},[],{"trials":1156,"activeCount":96},[],{"intervention":1158,"totalTrials":129,"cells":1159},"Botulinum toxin A (BoNT-A) 50U",{"EARLY_PHASE1":1160,"PHASE1":1162,"PHASE2":1164,"PHASE3":1166,"PHASE4":1181,"NA":1183},{"trials":1161,"activeCount":96},[],{"trials":1163,"activeCount":96},[],{"trials":1165,"activeCount":96},[],{"trials":1167,"activeCount":96},[1168],{"nctId":1169,"briefTitle":1170,"status":108,"phases":1171,"primaryCompletion":1172,"completion":1173,"start":1174,"enrollment":1175,"conditions":1176,"interventions":1178},"NCT02425176","Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological Diseases",[86,87],"2014-02","2014-04","2009-09",30,[1177],"Sialorrhea",[1158,1179,1180],"Botulinum toxin A (BoNT-A) 100U","Botulinum toxin A (BoNT-A) 200U",{"trials":1182,"activeCount":96},[],{"trials":1184,"activeCount":96},[],{"intervention":1179,"totalTrials":129,"cells":1186},{"EARLY_PHASE1":1187,"PHASE1":1189,"PHASE2":1191,"PHASE3":1193,"PHASE4":1199,"NA":1201},{"trials":1188,"activeCount":96},[],{"trials":1190,"activeCount":96},[],{"trials":1192,"activeCount":96},[],{"trials":1194,"activeCount":96},[1195],{"nctId":1169,"briefTitle":1170,"status":108,"phases":1196,"primaryCompletion":1172,"completion":1173,"start":1174,"enrollment":1175,"conditions":1197,"interventions":1198},[86,87],[1177],[1158,1179,1180],{"trials":1200,"activeCount":96},[],{"trials":1202,"activeCount":96},[],{"intervention":1180,"totalTrials":129,"cells":1204},{"EARLY_PHASE1":1205,"PHASE1":1207,"PHASE2":1209,"PHASE3":1211,"PHASE4":1217,"NA":1219},{"trials":1206,"activeCount":96},[],{"trials":1208,"activeCount":96},[],{"trials":1210,"activeCount":96},[],{"trials":1212,"activeCount":96},[1213],{"nctId":1169,"briefTitle":1170,"status":108,"phases":1214,"primaryCompletion":1172,"completion":1173,"start":1174,"enrollment":1175,"conditions":1215,"interventions":1216},[86,87],[1177],[1158,1179,1180],{"trials":1218,"activeCount":96},[],{"trials":1220,"activeCount":96},[],{"intervention":1222,"totalTrials":129,"cells":1223},"Pregabalin",{"EARLY_PHASE1":1224,"PHASE1":1226,"PHASE2":1228,"PHASE3":1230,"PHASE4":1240,"NA":1242},{"trials":1225,"activeCount":96},[],{"trials":1227,"activeCount":96},[],{"trials":1229,"activeCount":96},[],{"trials":1231,"activeCount":96},[1232],{"nctId":1233,"briefTitle":1234,"status":354,"phases":1235,"primaryCompletion":416,"completion":416,"start":1174,"enrollment":1236,"conditions":1237,"interventions":1239},"NCT01450345","Efficacy of Pre-operative Oral Pregabalin in Ambulatory Inguinal Hernia Repair for Post Operative Pain",[87],72,[1238,25],"Inguinal Hernia",[1222],{"trials":1241,"activeCount":96},[],{"trials":1243,"activeCount":96},[],{"intervention":1245,"totalTrials":129,"cells":1246},"Methylphenidate",{"EARLY_PHASE1":1247,"PHASE1":1249,"PHASE2":1251,"PHASE3":1253,"PHASE4":1264,"NA":1266},{"trials":1248,"activeCount":96},[],{"trials":1250,"activeCount":96},[],{"trials":1252,"activeCount":96},[],{"trials":1254,"activeCount":96},[1255],{"nctId":1256,"briefTitle":1257,"status":354,"phases":1258,"primaryCompletion":1259,"completion":415,"start":1260,"enrollment":1261,"conditions":1262,"interventions":1263},"NCT01497548","Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients",[87],"2012-09","2011-03",120,[23],[1245],{"trials":1265,"activeCount":96},[],{"trials":1267,"activeCount":96},[],{"intervention":1269,"totalTrials":129,"cells":1270},"Aminophylline",{"EARLY_PHASE1":1271,"PHASE1":1273,"PHASE2":1275,"PHASE3":1277,"PHASE4":1289,"NA":1291},{"trials":1272,"activeCount":96},[],{"trials":1274,"activeCount":96},[],{"trials":1276,"activeCount":96},[],{"trials":1278,"activeCount":96},[1279],{"nctId":1280,"briefTitle":1281,"status":354,"phases":1282,"primaryCompletion":875,"completion":875,"start":1283,"enrollment":1284,"conditions":1285,"interventions":1287},"NCT05933642","Diuretic Efficacy of Aminophylline and Furosemide Combination vs Furosemide Alone in Critically Ill Adults",[86,87],"2023-07-02",132,[1286],"Acute Kidney Injury",[1269,1288],"Frusemide",{"trials":1290,"activeCount":96},[],{"trials":1292,"activeCount":96},[],{"intervention":1288,"totalTrials":129,"cells":1294},{"EARLY_PHASE1":1295,"PHASE1":1297,"PHASE2":1299,"PHASE3":1301,"PHASE4":1307,"NA":1309},{"trials":1296,"activeCount":96},[],{"trials":1298,"activeCount":96},[],{"trials":1300,"activeCount":96},[],{"trials":1302,"activeCount":96},[1303],{"nctId":1280,"briefTitle":1281,"status":354,"phases":1304,"primaryCompletion":875,"completion":875,"start":1283,"enrollment":1284,"conditions":1305,"interventions":1306},[86,87],[1286],[1269,1288],{"trials":1308,"activeCount":96},[],{"trials":1310,"activeCount":96},[],{"intervention":1312,"totalTrials":129,"cells":1313},"Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy",{"EARLY_PHASE1":1314,"PHASE1":1316,"PHASE2":1318,"PHASE3":1320,"PHASE4":1335,"NA":1337},{"trials":1315,"activeCount":96},[],{"trials":1317,"activeCount":96},[],{"trials":1319,"activeCount":96},[],{"trials":1321,"activeCount":96},[1322],{"nctId":1323,"briefTitle":1324,"status":354,"phases":1325,"primaryCompletion":1326,"completion":1327,"start":1328,"enrollment":1329,"conditions":1330,"interventions":1333},"NCT05955157","Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma",[86,87],"2024-12","2025-06","2023-01-03",52,[1331,1332],"Pancreatic Ductal Adenocarcinoma","Advanced Solid Tumor",[1312,1334],"Tegafur Only Product",{"trials":1336,"activeCount":96},[],{"trials":1338,"activeCount":96},[],{"intervention":1334,"totalTrials":129,"cells":1340},{"EARLY_PHASE1":1341,"PHASE1":1343,"PHASE2":1345,"PHASE3":1347,"PHASE4":1353,"NA":1355},{"trials":1342,"activeCount":96},[],{"trials":1344,"activeCount":96},[],{"trials":1346,"activeCount":96},[],{"trials":1348,"activeCount":96},[1349],{"nctId":1323,"briefTitle":1324,"status":354,"phases":1350,"primaryCompletion":1326,"completion":1327,"start":1328,"enrollment":1329,"conditions":1351,"interventions":1352},[86,87],[1331,1332],[1312,1334],{"trials":1354,"activeCount":96},[],{"trials":1356,"activeCount":96},[],{"intervention":1358,"totalTrials":129,"cells":1359},"Lamictal®",{"EARLY_PHASE1":1360,"PHASE1":1362,"PHASE2":1364,"PHASE3":1366,"PHASE4":1380,"NA":1382},{"trials":1361,"activeCount":96},[],{"trials":1363,"activeCount":96},[],{"trials":1365,"activeCount":96},[],{"trials":1367,"activeCount":96},[1368],{"nctId":1369,"briefTitle":1370,"status":108,"phases":1371,"primaryCompletion":1372,"completion":1373,"start":1374,"enrollment":1375,"conditions":1376,"interventions":1378},"NCT00913107","Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia",[86,87],"2008-02","2008-06","2007-09",21,[1377],"Trigeminal Neuralgia",[1358,1379],"Tegretol®",{"trials":1381,"activeCount":96},[],{"trials":1383,"activeCount":96},[],{"intervention":1379,"totalTrials":129,"cells":1385},{"EARLY_PHASE1":1386,"PHASE1":1388,"PHASE2":1390,"PHASE3":1392,"PHASE4":1398,"NA":1400},{"trials":1387,"activeCount":96},[],{"trials":1389,"activeCount":96},[],{"trials":1391,"activeCount":96},[],{"trials":1393,"activeCount":96},[1394],{"nctId":1369,"briefTitle":1370,"status":108,"phases":1395,"primaryCompletion":1372,"completion":1373,"start":1374,"enrollment":1375,"conditions":1396,"interventions":1397},[86,87],[1377],[1358,1379],{"trials":1399,"activeCount":96},[],{"trials":1401,"activeCount":96},[],{"intervention":1403,"totalTrials":129,"cells":1404},"Cetuximab",{"EARLY_PHASE1":1405,"PHASE1":1407,"PHASE2":1409,"PHASE3":1422,"PHASE4":1424,"NA":1426},{"trials":1406,"activeCount":96},[],{"trials":1408,"activeCount":96},[],{"trials":1410,"activeCount":96},[1411],{"nctId":1412,"briefTitle":1413,"status":1414,"phases":1415,"primaryCompletion":1416,"completion":964,"start":1417,"enrollment":1418,"conditions":1419,"interventions":1421},"NCT01230476","Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma","TERMINATED",[86],"2013-05","2010-05",3,[1420],"Nasopharyngeal Carcinoma",[1403],{"trials":1423,"activeCount":96},[],{"trials":1425,"activeCount":96},[],{"trials":1427,"activeCount":96},[],{"intervention":1429,"totalTrials":129,"cells":1430},"Tramadol",{"EARLY_PHASE1":1431,"PHASE1":1433,"PHASE2":1435,"PHASE3":1449,"PHASE4":1451,"NA":1453},{"trials":1432,"activeCount":96},[],{"trials":1434,"activeCount":96},[],{"trials":1436,"activeCount":96},[1437],{"nctId":1438,"briefTitle":1439,"status":108,"phases":1440,"primaryCompletion":1441,"completion":1441,"start":1442,"enrollment":1443,"conditions":1444,"interventions":1447},"NCT03383315","Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients",[86],"2017-09-30","2017-07-01",191,[1445,1446],"Trauma","Opioid Analgesic Adverse Reaction",[1429,1448],"Metoclopramide",{"trials":1450,"activeCount":96},[],{"trials":1452,"activeCount":96},[],{"trials":1454,"activeCount":96},[],{"intervention":1448,"totalTrials":129,"cells":1456},{"EARLY_PHASE1":1457,"PHASE1":1459,"PHASE2":1461,"PHASE3":1467,"PHASE4":1469,"NA":1471},{"trials":1458,"activeCount":96},[],{"trials":1460,"activeCount":96},[],{"trials":1462,"activeCount":96},[1463],{"nctId":1438,"briefTitle":1439,"status":108,"phases":1464,"primaryCompletion":1441,"completion":1441,"start":1442,"enrollment":1443,"conditions":1465,"interventions":1466},[86],[1445,1446],[1429,1448],{"trials":1468,"activeCount":96},[],{"trials":1470,"activeCount":96},[],{"trials":1472,"activeCount":96},[],{"intervention":1474,"totalTrials":129,"cells":1475},"Probiotics",{"EARLY_PHASE1":1476,"PHASE1":1478,"PHASE2":1480,"PHASE3":1494,"PHASE4":1496,"NA":1498},{"trials":1477,"activeCount":96},[],{"trials":1479,"activeCount":96},[],{"trials":1481,"activeCount":96},[1482],{"nctId":1483,"briefTitle":1484,"status":108,"phases":1485,"primaryCompletion":1486,"completion":1486,"start":1487,"enrollment":1488,"conditions":1489,"interventions":1493},"NCT01792401","Probiotics in Enteral Feeding in Critically Ill Patients",[86],"2012-12","2012-01",49,[15,1490,1474,1491,1492],"Dietary Modification","Gut Failure","Treatment Outcomes",[1474],{"trials":1495,"activeCount":96},[],{"trials":1497,"activeCount":96},[],{"trials":1499,"activeCount":96},[],{"intervention":1501,"totalTrials":129,"cells":1502},"Odontopaste®",{"EARLY_PHASE1":1503,"PHASE1":1505,"PHASE2":1507,"PHASE3":1520,"PHASE4":1522,"NA":1524},{"trials":1504,"activeCount":96},[],{"trials":1506,"activeCount":96},[],{"trials":1508,"activeCount":96},[1509],{"nctId":1510,"briefTitle":1511,"status":108,"phases":1512,"primaryCompletion":1513,"completion":1513,"start":1514,"enrollment":417,"conditions":1515,"interventions":1517},"NCT03761264","Systemic and Local Antimicrobials in the Management of Dental Abscess in Children",[86],"2020-02-13","2018-09-18",[1516],"Dentoalveolar Abscess",[1501,1518,1519],"Pulpdent","Amoxicillin",{"trials":1521,"activeCount":96},[],{"trials":1523,"activeCount":96},[],{"trials":1525,"activeCount":96},[],{"intervention":1518,"totalTrials":129,"cells":1527},{"EARLY_PHASE1":1528,"PHASE1":1530,"PHASE2":1532,"PHASE3":1538,"PHASE4":1540,"NA":1542},{"trials":1529,"activeCount":96},[],{"trials":1531,"activeCount":96},[],{"trials":1533,"activeCount":96},[1534],{"nctId":1510,"briefTitle":1511,"status":108,"phases":1535,"primaryCompletion":1513,"completion":1513,"start":1514,"enrollment":417,"conditions":1536,"interventions":1537},[86],[1516],[1501,1518,1519],{"trials":1539,"activeCount":96},[],{"trials":1541,"activeCount":96},[],{"trials":1543,"activeCount":96},[],{"intervention":1519,"totalTrials":129,"cells":1545},{"EARLY_PHASE1":1546,"PHASE1":1548,"PHASE2":1550,"PHASE3":1556,"PHASE4":1558,"NA":1560},{"trials":1547,"activeCount":96},[],{"trials":1549,"activeCount":96},[],{"trials":1551,"activeCount":96},[1552],{"nctId":1510,"briefTitle":1511,"status":108,"phases":1553,"primaryCompletion":1513,"completion":1513,"start":1514,"enrollment":417,"conditions":1554,"interventions":1555},[86],[1516],[1501,1518,1519],{"trials":1557,"activeCount":96},[],{"trials":1559,"activeCount":96},[],{"trials":1561,"activeCount":96},[],{"intervention":1563,"totalTrials":129,"cells":1564},"Talazoparib",{"EARLY_PHASE1":1565,"PHASE1":1567,"PHASE2":1569,"PHASE3":1582,"PHASE4":1584,"NA":1586},{"trials":1566,"activeCount":96},[],{"trials":1568,"activeCount":96},[],{"trials":1570,"activeCount":96},[1571],{"nctId":1572,"briefTitle":1573,"status":354,"phases":1574,"primaryCompletion":1575,"completion":1576,"start":1577,"enrollment":417,"conditions":1578,"interventions":1581},"NCT05288127","Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature",[86],"2024-06","2025-11","2022-03-08",[1579,1580],"HRD 100 Gene Expression High","Triple Negative Breast Cancer",[1563],{"trials":1583,"activeCount":96},[],{"trials":1585,"activeCount":96},[],{"trials":1587,"activeCount":96},[],{"intervention":1589,"totalTrials":129,"cells":1590},"Sillymarin",{"EARLY_PHASE1":1591,"PHASE1":1593,"PHASE2":1595,"PHASE3":1607,"PHASE4":1609,"NA":1611},{"trials":1592,"activeCount":96},[],{"trials":1594,"activeCount":96},[],{"trials":1596,"activeCount":96},[1597],{"nctId":1598,"briefTitle":1599,"status":108,"phases":1600,"primaryCompletion":1601,"completion":1601,"start":1602,"enrollment":1603,"conditions":1604,"interventions":1606},"NCT02006498","Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)",[86],"2015-12","2012-06",99,[1605],"Non-alcoholic Fatty Liver Disease",[1589],{"trials":1608,"activeCount":96},[],{"trials":1610,"activeCount":96},[],{"trials":1612,"activeCount":96},[],{"intervention":1614,"totalTrials":129,"cells":1615},"Bupropion hydrochloride sustained-release",{"EARLY_PHASE1":1616,"PHASE1":1618,"PHASE2":1620,"PHASE3":1632,"PHASE4":1634,"NA":1636},{"trials":1617,"activeCount":96},[],{"trials":1619,"activeCount":96},[],{"trials":1621,"activeCount":96},[1622],{"nctId":1623,"briefTitle":1624,"status":108,"phases":1625,"primaryCompletion":1626,"completion":1626,"start":1601,"enrollment":966,"conditions":1627,"interventions":1631},"NCT02593396","Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men",[86],"2017-12",[1628,1629,1630],"Sexual Dysfunctions, Psychological","Hypoactive Sexual Desire Disorder","Erectile Dysfunctions",[1614],{"trials":1633,"activeCount":96},[],{"trials":1635,"activeCount":96},[],{"trials":1637,"activeCount":96},[],{"intervention":1639,"totalTrials":129,"cells":1640},"Lignosus rhinoceros TM02®",{"EARLY_PHASE1":1641,"PHASE1":1643,"PHASE2":1645,"PHASE3":1657,"PHASE4":1659,"NA":1661},{"trials":1642,"activeCount":96},[],{"trials":1644,"activeCount":96},[],{"trials":1646,"activeCount":96},[1647],{"nctId":1648,"briefTitle":1649,"status":108,"phases":1650,"primaryCompletion":1651,"completion":1651,"start":1652,"enrollment":1653,"conditions":1654,"interventions":1656},"NCT06451328","Lignosus Rhinoceros TM02® as a Complementary Therapy for Uncontrolled Asthma",[86],"2023-02-28","2022-03-01",17,[1655],"Asthma",[1639],{"trials":1658,"activeCount":96},[],{"trials":1660,"activeCount":96},[],{"trials":1662,"activeCount":96},[],{"intervention":1664,"totalTrials":129,"cells":1665},"Platelet-Rich Plasma",{"EARLY_PHASE1":1666,"PHASE1":1668,"PHASE2":1683,"PHASE3":1685,"PHASE4":1687,"NA":1689},{"trials":1667,"activeCount":96},[],{"trials":1669,"activeCount":96},[1670],{"nctId":1671,"briefTitle":1672,"status":108,"phases":1673,"primaryCompletion":1674,"completion":1675,"start":1676,"enrollment":148,"conditions":1677,"interventions":1681},"NCT04640662","The Effects of Platelet-Rich Plasma Versus Prolotherapy On Rotator Cuff Tendinopathy: A Randomized Controlled Trial.",[85],"2021-06-30","2021-09-25","2020-02-17",[1678,1679,1680],"Rotator Cuff Tendinosis","Supraspinatus Strain","PRP",[1664,1682],"Prolotherapy",{"trials":1684,"activeCount":96},[],{"trials":1686,"activeCount":96},[],{"trials":1688,"activeCount":96},[],{"trials":1690,"activeCount":96},[],{"intervention":1682,"totalTrials":129,"cells":1692},{"EARLY_PHASE1":1693,"PHASE1":1695,"PHASE2":1701,"PHASE3":1703,"PHASE4":1705,"NA":1707},{"trials":1694,"activeCount":96},[],{"trials":1696,"activeCount":96},[1697],{"nctId":1671,"briefTitle":1672,"status":108,"phases":1698,"primaryCompletion":1674,"completion":1675,"start":1676,"enrollment":148,"conditions":1699,"interventions":1700},[85],[1678,1679,1680],[1664,1682],{"trials":1702,"activeCount":96},[],{"trials":1704,"activeCount":96},[],{"trials":1706,"activeCount":96},[],{"trials":1708,"activeCount":96},[],{"intervention":1710,"totalTrials":129,"cells":1711},"oxygen",{"EARLY_PHASE1":1712,"PHASE1":1714,"PHASE2":1726,"PHASE3":1728,"PHASE4":1730,"NA":1732},{"trials":1713,"activeCount":96},[],{"trials":1715,"activeCount":96},[1716],{"nctId":1717,"briefTitle":1718,"status":108,"phases":1719,"primaryCompletion":1720,"completion":1721,"start":1417,"enrollment":510,"conditions":1722,"interventions":1725},"NCT01157624","Application of Nasal Cannula With Oxygen Versus Air During Eye Surgery Under Local Anaesthetic",[85],"2010-10","2010-12",[1723,1724],"Hypoxia","Hypercapnia",[1710,1710],{"trials":1727,"activeCount":96},[],{"trials":1729,"activeCount":96},[],{"trials":1731,"activeCount":96},[],{"trials":1733,"activeCount":96},[],{"intervention":1735,"totalTrials":129,"cells":1736},"Brand name: Andrographis paniculata (Shine Hempedu Bumi) 1000mg",{"EARLY_PHASE1":1737,"PHASE1":1739,"PHASE2":1754,"PHASE3":1756,"PHASE4":1758,"NA":1760},{"trials":1738,"activeCount":96},[],{"trials":1740,"activeCount":96},[1741],{"nctId":1742,"briefTitle":1743,"status":354,"phases":1744,"primaryCompletion":1745,"completion":1746,"start":1747,"enrollment":11,"conditions":1748,"interventions":1751},"NCT04161404","Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition",[85],"2019-12-31","2020-12-31","2019-08-21",[1749,1750],"Pharmacokinetics","Molecular Mechanisms of Pharmacological Action",[1735,1752,1753],"Brand name: Andrographis paniculata (Shine Hempedu Bumi) 2000mg","Metformin (Glucophage) 1000mg",{"trials":1755,"activeCount":96},[],{"trials":1757,"activeCount":96},[],{"trials":1759,"activeCount":96},[],{"trials":1761,"activeCount":96},[],{"intervention":1752,"totalTrials":129,"cells":1763},{"EARLY_PHASE1":1764,"PHASE1":1766,"PHASE2":1772,"PHASE3":1774,"PHASE4":1776,"NA":1778},{"trials":1765,"activeCount":96},[],{"trials":1767,"activeCount":96},[1768],{"nctId":1742,"briefTitle":1743,"status":354,"phases":1769,"primaryCompletion":1745,"completion":1746,"start":1747,"enrollment":11,"conditions":1770,"interventions":1771},[85],[1749,1750],[1735,1752,1753],{"trials":1773,"activeCount":96},[],{"trials":1775,"activeCount":96},[],{"trials":1777,"activeCount":96},[],{"trials":1779,"activeCount":96},[],{"intervention":1753,"totalTrials":129,"cells":1781},{"EARLY_PHASE1":1782,"PHASE1":1784,"PHASE2":1790,"PHASE3":1792,"PHASE4":1794,"NA":1796},{"trials":1783,"activeCount":96},[],{"trials":1785,"activeCount":96},[1786],{"nctId":1742,"briefTitle":1743,"status":354,"phases":1787,"primaryCompletion":1745,"completion":1746,"start":1747,"enrollment":11,"conditions":1788,"interventions":1789},[85],[1749,1750],[1735,1752,1753],{"trials":1791,"activeCount":96},[],{"trials":1793,"activeCount":96},[],{"trials":1795,"activeCount":96},[],{"trials":1797,"activeCount":96},[],{"intervention":439,"totalTrials":129,"cells":1799},{"EARLY_PHASE1":1800,"PHASE1":1802,"PHASE2":1808,"PHASE3":1810,"PHASE4":1812,"NA":1814},{"trials":1801,"activeCount":96},[],{"trials":1803,"activeCount":96},[1804],{"nctId":431,"briefTitle":432,"status":354,"phases":1805,"primaryCompletion":434,"completion":434,"start":435,"enrollment":395,"conditions":1806,"interventions":1807},[85],[437],[424,439],{"trials":1809,"activeCount":96},[],{"trials":1811,"activeCount":96},[],{"trials":1813,"activeCount":96},[],{"trials":1815,"activeCount":96},[],{"intervention":1817,"totalTrials":129,"cells":1818},"0.85% synthetic antimicrobial peptide TAPS-18",{"EARLY_PHASE1":1819,"PHASE1":1830,"PHASE2":1832,"PHASE3":1834,"PHASE4":1836,"NA":1838},{"trials":1820,"activeCount":96},[1821],{"nctId":1822,"briefTitle":1823,"status":108,"phases":1824,"primaryCompletion":1825,"completion":1825,"start":1826,"enrollment":28,"conditions":1827,"interventions":1828},"NCT05125718","Clinical and Metagenomic Investigation of Antimicrobial Peptide Gel in Periodontal Treatment.",[84],"2021-04-30","2021-01-01",[18],[1817,1829],"0.9% normal saline",{"trials":1831,"activeCount":96},[],{"trials":1833,"activeCount":96},[],{"trials":1835,"activeCount":96},[],{"trials":1837,"activeCount":96},[],{"trials":1839,"activeCount":96},[],{"intervention":1829,"totalTrials":129,"cells":1841},{"EARLY_PHASE1":1842,"PHASE1":1848,"PHASE2":1850,"PHASE3":1852,"PHASE4":1854,"NA":1856},{"trials":1843,"activeCount":96},[1844],{"nctId":1822,"briefTitle":1823,"status":108,"phases":1845,"primaryCompletion":1825,"completion":1825,"start":1826,"enrollment":28,"conditions":1846,"interventions":1847},[84],[18],[1817,1829],{"trials":1849,"activeCount":96},[],{"trials":1851,"activeCount":96},[],{"trials":1853,"activeCount":96},[],{"trials":1855,"activeCount":96},[],{"trials":1857,"activeCount":96},[],{"intervention":923,"totalTrials":1418,"cells":1859},{"EARLY_PHASE1":1860,"PHASE1":1862,"PHASE2":1864,"PHASE3":1866,"PHASE4":1868,"NA":1881},{"trials":1861,"activeCount":96},[],{"trials":1863,"activeCount":96},[],{"trials":1865,"activeCount":96},[],{"trials":1867,"activeCount":96},[],{"trials":1869,"activeCount":96},[1870],{"nctId":1871,"briefTitle":1872,"status":108,"phases":1873,"primaryCompletion":1874,"completion":1874,"start":1875,"enrollment":1876,"conditions":1877,"interventions":1879},"NCT01833676","To Compare Effect of Sevoflurane Versus Desflurane on the Return of Swallowing Reflexes in the Elderly",[88],"2013-04","2012-03",51,[1878],"Pulmonary Aspiration",[923,1880],"Desflurane",{"trials":1882,"activeCount":96},[1883,1893],{"nctId":1884,"briefTitle":1885,"status":108,"phases":1886,"primaryCompletion":1887,"completion":1887,"start":1888,"enrollment":1889,"conditions":1890,"interventions":1892},"NCT01083953","Optimal End-Tidal (ET) Sevoflurane and Desflurane Concentration for Extubation of Supreme Laryngeal Mask Airway (LMA) in Adults",[89],"2010-07","2009-11",54,[1891],"Airway Complications",[923,1880],{"nctId":1894,"briefTitle":1895,"status":108,"phases":1896,"primaryCompletion":1897,"completion":1897,"start":1898,"enrollment":1175,"conditions":1899,"interventions":1903},"NCT04410211","Comparison Between Two Types of Sedation for Elective Upper Endoscopy Procedures",[89],"2019-11-30","2018-06-01",[1900,1901,1902],"Gastro Esophageal Reflux","Gastric Ulcer","Sedation Complication",[923,1904],"Midazolam",{"intervention":375,"totalTrials":1418,"cells":1906},{"EARLY_PHASE1":1907,"PHASE1":1909,"PHASE2":1911,"PHASE3":1913,"PHASE4":1915,"NA":1921},{"trials":1908,"activeCount":96},[],{"trials":1910,"activeCount":96},[],{"trials":1912,"activeCount":96},[],{"trials":1914,"activeCount":96},[],{"trials":1916,"activeCount":96},[1917],{"nctId":364,"briefTitle":365,"status":108,"phases":1918,"primaryCompletion":367,"completion":368,"start":369,"enrollment":370,"conditions":1919,"interventions":1920},[88],[372,373],[375,339],{"trials":1922,"activeCount":96},[1923,1927],{"nctId":389,"briefTitle":390,"status":354,"phases":1924,"primaryCompletion":392,"completion":393,"start":394,"enrollment":395,"conditions":1925,"interventions":1926},[89],[25,397,398],[375,339],{"nctId":401,"briefTitle":402,"status":108,"phases":1928,"primaryCompletion":404,"completion":404,"start":405,"enrollment":406,"conditions":1929,"interventions":1930},[89],[25,408,409],[375,387],{"intervention":1880,"totalTrials":92,"cells":1932},{"EARLY_PHASE1":1933,"PHASE1":1935,"PHASE2":1937,"PHASE3":1939,"PHASE4":1941,"NA":1947},{"trials":1934,"activeCount":96},[],{"trials":1936,"activeCount":96},[],{"trials":1938,"activeCount":96},[],{"trials":1940,"activeCount":96},[],{"trials":1942,"activeCount":96},[1943],{"nctId":1871,"briefTitle":1872,"status":108,"phases":1944,"primaryCompletion":1874,"completion":1874,"start":1875,"enrollment":1876,"conditions":1945,"interventions":1946},[88],[1878],[923,1880],{"trials":1948,"activeCount":96},[1949],{"nctId":1884,"briefTitle":1885,"status":108,"phases":1950,"primaryCompletion":1887,"completion":1887,"start":1888,"enrollment":1889,"conditions":1951,"interventions":1952},[89],[1891],[923,1880],{"intervention":1954,"totalTrials":129,"cells":1955},"Methadone",{"EARLY_PHASE1":1956,"PHASE1":1958,"PHASE2":1960,"PHASE3":1962,"PHASE4":1964,"NA":1966},{"trials":1957,"activeCount":96},[],{"trials":1959,"activeCount":96},[],{"trials":1961,"activeCount":96},[],{"trials":1963,"activeCount":96},[],{"trials":1965,"activeCount":96},[],{"trials":1967,"activeCount":96},[1968],{"nctId":1969,"briefTitle":1970,"status":1414,"phases":1971,"primaryCompletion":1972,"completion":1972,"start":1973,"enrollment":1974,"conditions":1975,"interventions":1977},"NCT02698098","Comparative Evaluation of PUSPENs and C&Cs",[],"2015-09","2012-08",281,[1976],"Opioid-Related Disorders",[1954],{"intervention":1979,"totalTrials":129,"cells":1980},"Helicobacter pylori eradication therapy",{"EARLY_PHASE1":1981,"PHASE1":1983,"PHASE2":1985,"PHASE3":1987,"PHASE4":1989,"NA":1991},{"trials":1982,"activeCount":96},[],{"trials":1984,"activeCount":96},[],{"trials":1986,"activeCount":96},[],{"trials":1988,"activeCount":96},[],{"trials":1990,"activeCount":96},[],{"trials":1992,"activeCount":96},[1993],{"nctId":1994,"briefTitle":1995,"status":108,"phases":1996,"primaryCompletion":1601,"completion":1997,"start":435,"enrollment":1998,"conditions":1999,"interventions":2002},"NCT02108704","Helicobacter Pylori Eradication Study in Parkinson's Disease",[89],"2016-05",75,[2000,2001],"Parkinson's Disease","Helicobacter Pylori Infection",[1979],{"intervention":2004,"totalTrials":129,"cells":2005},"Lignocaine, Dexmedetomidine, Sevoflurane, Paracetamol, Parecoxib",{"EARLY_PHASE1":2006,"PHASE1":2008,"PHASE2":2010,"PHASE3":2012,"PHASE4":2014,"NA":2016},{"trials":2007,"activeCount":96},[],{"trials":2009,"activeCount":96},[],{"trials":2011,"activeCount":96},[],{"trials":2013,"activeCount":96},[],{"trials":2015,"activeCount":96},[],{"trials":2017,"activeCount":96},[2018],{"nctId":2019,"briefTitle":2020,"status":108,"phases":2021,"primaryCompletion":2022,"completion":2022,"start":2023,"enrollment":669,"conditions":2024,"interventions":2026},"NCT05681429","Accelerated Recovery Following Opioid-free Anaesthesia in Supratentorial Craniotomy",[89],"2024-01-31","2023-01-01",[2025],"Opioid-Free Anaesthesia",[2004],{"intervention":2028,"totalTrials":129,"cells":2029},"alfentanil",{"EARLY_PHASE1":2030,"PHASE1":2032,"PHASE2":2034,"PHASE3":2036,"PHASE4":2038,"NA":2040},{"trials":2031,"activeCount":96},[],{"trials":2033,"activeCount":96},[],{"trials":2035,"activeCount":96},[],{"trials":2037,"activeCount":96},[],{"trials":2039,"activeCount":96},[],{"trials":2041,"activeCount":96},[2042],{"nctId":2043,"briefTitle":2044,"status":108,"phases":2045,"primaryCompletion":2046,"completion":2047,"start":2048,"enrollment":1175,"conditions":2049,"interventions":2051},"NCT01371968","Optimal Dose of Alfentanil for Removal of Supreme Laryngeal Mask Airway During Emergence From Desflurane Anaesthesia",[89],"2011-08","2011-11","2011-02",[2050],"Airway Response",[2028],{"intervention":2053,"totalTrials":129,"cells":2054},"Blood samples",{"EARLY_PHASE1":2055,"PHASE1":2057,"PHASE2":2059,"PHASE3":2061,"PHASE4":2063,"NA":2065},{"trials":2056,"activeCount":96},[],{"trials":2058,"activeCount":96},[],{"trials":2060,"activeCount":96},[],{"trials":2062,"activeCount":96},[],{"trials":2064,"activeCount":96},[],{"trials":2066,"activeCount":96},[2067],{"nctId":2068,"briefTitle":2069,"status":2070,"phases":2071,"primaryCompletion":806,"completion":1626,"start":2072,"enrollment":96,"conditions":2073,"interventions":2077},"NCT02866630","Coronary Sinus Blood Sevoflurane and Desflurane Concentration and Lactate Changes in Patients Undergoing Heart Surgery","WITHDRAWN",[],"2017-07-20",[2074,2075,2076],"Myocardial Reperfusion Injury","Heart Diseases","Postoperative Complications",[2053],{"intervention":1904,"totalTrials":129,"cells":2079},{"EARLY_PHASE1":2080,"PHASE1":2082,"PHASE2":2084,"PHASE3":2086,"PHASE4":2088,"NA":2090},{"trials":2081,"activeCount":96},[],{"trials":2083,"activeCount":96},[],{"trials":2085,"activeCount":96},[],{"trials":2087,"activeCount":96},[],{"trials":2089,"activeCount":96},[],{"trials":2091,"activeCount":96},[2092],{"nctId":1894,"briefTitle":1895,"status":108,"phases":2093,"primaryCompletion":1897,"completion":1897,"start":1898,"enrollment":1175,"conditions":2094,"interventions":2095},[89],[1900,1901,1902],[923,1904],{"intervention":2097,"totalTrials":129,"cells":2098},"Intravitreal Ranibizumab",{"EARLY_PHASE1":2099,"PHASE1":2101,"PHASE2":2103,"PHASE3":2105,"PHASE4":2107,"NA":2109},{"trials":2100,"activeCount":96},[],{"trials":2102,"activeCount":96},[],{"trials":2104,"activeCount":96},[],{"trials":2106,"activeCount":96},[],{"trials":2108,"activeCount":96},[],{"trials":2110,"activeCount":96},[2111],{"nctId":2112,"briefTitle":2113,"status":354,"phases":2114,"primaryCompletion":1602,"start":2115,"enrollment":1175,"conditions":2116,"interventions":2118},"NCT01626339","Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter",[89],"2012-04",[2117],"Age Related Macular Degeneration",[2097,2119],"Intravitreal bevacizumab",{"intervention":2119,"totalTrials":129,"cells":2121},{"EARLY_PHASE1":2122,"PHASE1":2124,"PHASE2":2126,"PHASE3":2128,"PHASE4":2130,"NA":2132},{"trials":2123,"activeCount":96},[],{"trials":2125,"activeCount":96},[],{"trials":2127,"activeCount":96},[],{"trials":2129,"activeCount":96},[],{"trials":2131,"activeCount":96},[],{"trials":2133,"activeCount":96},[2134],{"nctId":2112,"briefTitle":2113,"status":354,"phases":2135,"primaryCompletion":1602,"start":2115,"enrollment":1175,"conditions":2136,"interventions":2137},[89],[2117],[2097,2119],{"intervention":2139,"totalTrials":129,"cells":2140},"platelet-rich fibrin and calcium sulfate",{"EARLY_PHASE1":2141,"PHASE1":2143,"PHASE2":2145,"PHASE3":2147,"PHASE4":2149,"NA":2151},{"trials":2142,"activeCount":96},[],{"trials":2144,"activeCount":96},[],{"trials":2146,"activeCount":96},[],{"trials":2148,"activeCount":96},[],{"trials":2150,"activeCount":96},[],{"trials":2152,"activeCount":96},[2153],{"nctId":2154,"briefTitle":2155,"status":108,"phases":2156,"primaryCompletion":2157,"completion":2158,"start":2159,"enrollment":2160,"conditions":2161,"interventions":2163},"NCT03851289","Combination of Platelet-Rich Fibrin and Calcium Sulfate in Socket Augmentation",[89],"2017-07-14","2018-02-06","2016-04-22",10,[2162],"Tooth Extraction",[2139,2164],"platelet-rich fibrin and xenograft",{"intervention":2164,"totalTrials":129,"cells":2166},{"EARLY_PHASE1":2167,"PHASE1":2169,"PHASE2":2171,"PHASE3":2173,"PHASE4":2175,"NA":2177},{"trials":2168,"activeCount":96},[],{"trials":2170,"activeCount":96},[],{"trials":2172,"activeCount":96},[],{"trials":2174,"activeCount":96},[],{"trials":2176,"activeCount":96},[],{"trials":2178,"activeCount":96},[2179],{"nctId":2154,"briefTitle":2155,"status":108,"phases":2180,"primaryCompletion":2157,"completion":2158,"start":2159,"enrollment":2160,"conditions":2181,"interventions":2182},[89],[2162],[2139,2164],{"intervention":2184,"totalTrials":129,"cells":2185},"Tranexamic Acid",{"EARLY_PHASE1":2186,"PHASE1":2188,"PHASE2":2190,"PHASE3":2192,"PHASE4":2194,"NA":2196},{"trials":2187,"activeCount":96},[],{"trials":2189,"activeCount":96},[],{"trials":2191,"activeCount":96},[],{"trials":2193,"activeCount":96},[],{"trials":2195,"activeCount":96},[],{"trials":2197,"activeCount":96},[2198],{"nctId":2199,"briefTitle":2200,"status":108,"phases":2201,"primaryCompletion":2115,"completion":2202,"start":2203,"enrollment":395,"conditions":2204,"interventions":2206},"NCT01600599","Reducing Post Operative Bleeding Following Cabg",[89],"2012-05","2011-01",[2205],"Post CABG Bleeding",[2184,2207],"saline",{"intervention":2207,"totalTrials":129,"cells":2209},{"EARLY_PHASE1":2210,"PHASE1":2212,"PHASE2":2214,"PHASE3":2216,"PHASE4":2218,"NA":2220},{"trials":2211,"activeCount":96},[],{"trials":2213,"activeCount":96},[],{"trials":2215,"activeCount":96},[],{"trials":2217,"activeCount":96},[],{"trials":2219,"activeCount":96},[],{"trials":2221,"activeCount":96},[2222],{"nctId":2199,"briefTitle":2200,"status":108,"phases":2223,"primaryCompletion":2115,"completion":2202,"start":2203,"enrollment":395,"conditions":2224,"interventions":2225},[89],[2205],[2184,2207],{"intervention":2227,"totalTrials":129,"cells":2228},"Fluoridated toothpaste",{"EARLY_PHASE1":2229,"PHASE1":2231,"PHASE2":2233,"PHASE3":2235,"PHASE4":2237,"NA":2239},{"trials":2230,"activeCount":96},[],{"trials":2232,"activeCount":96},[],{"trials":2234,"activeCount":96},[],{"trials":2236,"activeCount":96},[],{"trials":2238,"activeCount":96},[],{"trials":2240,"activeCount":96},[2241],{"nctId":2242,"briefTitle":2243,"status":354,"phases":2244,"primaryCompletion":368,"completion":1016,"start":2245,"enrollment":1175,"conditions":2246,"interventions":2247},"NCT04788550","The Effect of Different Remineralizing Agents on White Spot Lesions and Dental Plaque During Orthodontic Retention",[89],"2021-03-17",[20],[2227,2248,2249],"fluoride varnish","CPP-ACP plus crème group",{"intervention":2248,"totalTrials":129,"cells":2251},{"EARLY_PHASE1":2252,"PHASE1":2254,"PHASE2":2256,"PHASE3":2258,"PHASE4":2260,"NA":2262},{"trials":2253,"activeCount":96},[],{"trials":2255,"activeCount":96},[],{"trials":2257,"activeCount":96},[],{"trials":2259,"activeCount":96},[],{"trials":2261,"activeCount":96},[],{"trials":2263,"activeCount":96},[2264],{"nctId":2242,"briefTitle":2243,"status":354,"phases":2265,"primaryCompletion":368,"completion":1016,"start":2245,"enrollment":1175,"conditions":2266,"interventions":2267},[89],[20],[2227,2248,2249],{"intervention":2249,"totalTrials":129,"cells":2269},{"EARLY_PHASE1":2270,"PHASE1":2272,"PHASE2":2274,"PHASE3":2276,"PHASE4":2278,"NA":2280},{"trials":2271,"activeCount":96},[],{"trials":2273,"activeCount":96},[],{"trials":2275,"activeCount":96},[],{"trials":2277,"activeCount":96},[],{"trials":2279,"activeCount":96},[],{"trials":2281,"activeCount":96},[2282],{"nctId":2242,"briefTitle":2243,"status":354,"phases":2283,"primaryCompletion":368,"completion":1016,"start":2245,"enrollment":1175,"conditions":2284,"interventions":2285},[89],[20],[2227,2248,2249],{"intervention":2287,"totalTrials":129,"cells":2288},"Probiotic",{"EARLY_PHASE1":2289,"PHASE1":2291,"PHASE2":2293,"PHASE3":2295,"PHASE4":2297,"NA":2299},{"trials":2290,"activeCount":96},[],{"trials":2292,"activeCount":96},[],{"trials":2294,"activeCount":96},[],{"trials":2296,"activeCount":96},[],{"trials":2298,"activeCount":96},[],{"trials":2300,"activeCount":96},[2301],{"nctId":2302,"briefTitle":2303,"status":108,"phases":2304,"primaryCompletion":2305,"completion":2305,"start":2306,"enrollment":1236,"conditions":2307,"interventions":2309},"NCT03377322","Trial of Probiotics for Constipation in Parkinson's Disease",[89],"2019-01-31","2017-12-01",[2308],"Parkinson Disease",[2287],{"intervention":2311,"totalTrials":129,"cells":2312},"Vortioxetine",{"EARLY_PHASE1":2313,"PHASE1":2315,"PHASE2":2317,"PHASE3":2319,"PHASE4":2321,"NA":2323},{"trials":2314,"activeCount":96},[],{"trials":2316,"activeCount":96},[],{"trials":2318,"activeCount":96},[],{"trials":2320,"activeCount":96},[],{"trials":2322,"activeCount":96},[],{"trials":2324,"activeCount":96},[2325],{"nctId":2326,"briefTitle":2327,"status":354,"phases":2328,"primaryCompletion":2329,"completion":2329,"start":2330,"enrollment":2331,"conditions":2332,"interventions":2335},"NCT04253678","Vortioxetine for Cancer Patients With Depression: An Observational Study",[],"2020-07","2019-12-12",140,[2333,2334],"Major Depressive Disorder","Cancer",[2311],{"intervention":421,"totalTrials":129,"cells":2337},{"EARLY_PHASE1":2338,"PHASE1":2340,"PHASE2":2342,"PHASE3":2344,"PHASE4":2346,"NA":2348},{"trials":2339,"activeCount":96},[],{"trials":2341,"activeCount":96},[],{"trials":2343,"activeCount":96},[],{"trials":2345,"activeCount":96},[],{"trials":2347,"activeCount":96},[],{"trials":2349,"activeCount":96},[2350],{"nctId":412,"briefTitle":413,"status":108,"phases":2351,"primaryCompletion":415,"completion":415,"start":416,"enrollment":417,"conditions":2352,"interventions":2353},[89],[419],[421,339,422],{"intervention":422,"totalTrials":129,"cells":2355},{"EARLY_PHASE1":2356,"PHASE1":2358,"PHASE2":2360,"PHASE3":2362,"PHASE4":2364,"NA":2366},{"trials":2357,"activeCount":96},[],{"trials":2359,"activeCount":96},[],{"trials":2361,"activeCount":96},[],{"trials":2363,"activeCount":96},[],{"trials":2365,"activeCount":96},[],{"trials":2367,"activeCount":96},[2368],{"nctId":412,"briefTitle":413,"status":108,"phases":2369,"primaryCompletion":415,"completion":415,"start":416,"enrollment":417,"conditions":2370,"interventions":2371},[89],[419],[421,339,422]]